| | | |
| Cellulitis extending less than 2 cm from the wound and at least two of the following: erythema, induration, pain, purulence, tenderness, or warmth; limited to skin or superficial tissues; no evidence of systemic illness
| Abscess without surrounding cellulitis: incision and drainage, destruction of loculations, dry dressing Superficial infections (e.g., impetigo, abrasions, lacerations): topical mupirocin (Bactroban); bacitracin and neomycin less effective Deeper infections: oral penicillin, first-generation cephalosporin, macrolide, or clindamycin
| |
| At least one of the following: cellulitis extending 2 cm or more from wound; deep tissue abscess; gangrene; involvement of fascia; lymphangitis; evidence of muscle, tendon, joint, or bone involvement
| Cellulitis: five-day course of penicillinase-resistant penicillin or first-generation cephalosporin; clindamycin or erythromycin for patients allergic to penicillin Bite wounds: five- to 10-day course of amoxicillin/clavulanate (Augmentin); doxycycline or trimethoprim/sulfamethoxazole, or fluoroquinolone plus clindamycin for patients allergic to penicillin
| |
| Acidosis, fever, hyperglycemia, hypotension, leukocytosis, mental status changes, tachycardia, vomiting
| In most cases, hospitalization and initial treatment with parenteral antibiotics Cellulitis: penicillinase-resistant penicillin, first-generation cephalosporin, clindamycin, or vancomycin Bite wounds: ampicillin/sulbactam (Unasyn), ertapenem (Invanz), or doxycycline
| |
| | | |